Donald A. Bergstrom, President, R&D at Relay Therapeutics, Inc. (RLAY), sold 648 shares at $6.26 ($4K) on 2024-06-27, disclosed to the SEC on 2024-07-01.
Open-market sale of $4k RLAY by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RLAY | SELL | 2026-07-08 | $162K | — | Filing → |
| RLAY | SELL | 2026-06-24 | $1.6M | — | Filing → |
| RLAY | SELL | 2026-04-30 | $22K | — | Filing → |